Preferred Label : elotuzumab;
MeSH note : a humanized monoclonal antibody that selectively targets glycoproteins expressed on
myeloma cells;
CISMeF synonym : HuLuc63;
MeSH hyponym : PDL063;
Is substance : O;
UNII : 1351PE5UGS;
Origin ID : C546027;
UMLS CUI : C1832049;
ATC code(s)
CISMeF manual mappings
Currated CISMeF NLP mapping
MeSH term(s) associated for indexing
Pharmacological action(s)
Record concept(s)
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
https://www.has-sante.fr/jcms/p_3402816/fr/empliciti-elotuzumab-myelome-multiple
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
Product containing only elotuzumab in parenteral dose form (medicinal product form)
infusions, intravenous
antineoplastic combined chemotherapy protocols
antineoplastic agents
elotuzumab
Lenalidomide
dexamethasone
Elo-Rd Regimen
adult
evaluation of the transparency committee
multiple myeloma
elotuzumab
---
https://www.has-sante.fr/jcms/p_3406109/fr/empliciti-elotuzumab-myelome-multiple-en-rechute-et-refractaire
2023
false
false
false
France
French
evaluation of the transparency committee
treatment outcome
insurance, health, reimbursement
Empliciti
elotuzumab
multiple myeloma
Refractory Multiple Myeloma
Recurrent Multiple Myeloma
elotuzumab
antineoplastic agents
infusions, intravenous
Dexamethasone/Elotuzumab/Pomalidomide Regimen
---
https://www.pharmactuel.com/index.php/pharmactuel/article/view/1209
2018
false
false
false
Canada
French
journal article
treatment outcome
disease-free survival
carfilzomib
elotuzumab
daratumumab
antineoplastic agents
antineoplastic agents
ixazomib
recurrence
multiple myeloma
oligopeptides
antibodies, monoclonal, humanized
antibodies, monoclonal
boron compounds
glycine
glycine
indoles
hydroxamic acids
Panobinostat
---
https://www.ema.europa.eu/medicines/human/EPAR/Empliciti
2016
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
antibodies, monoclonal, humanized
elotuzumab
drug approval
europe
treatment outcome
product surveillance, postmarketing
multiple myeloma
antineoplastic combined chemotherapy protocols
adult
infusions, intravenous
SLAMF7 protein, human
dexamethasone
Infusion-Related Reaction
infusions, intravenous
drug interactions
pregnancy
breast feeding
survival analysis
elotuzumab
Elo-Rd Regimen
Dexamethasone/Elotuzumab/Pomalidomide Regimen
elotuzumab
antibodies, monoclonal, humanized
receptors, immunologic
thalidomide
Lenalidomide
---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00323
2016
false
false
false
Canada
French
popular works
elotuzumab
elotuzumab
antibodies, monoclonal, humanized
---